SlideShare ist ein Scribd-Unternehmen logo

Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma

•Als PPT, PDF herunterladen•
•
PeerVoice
PeerVoice

Brian I. Rini, MD, FASCO, Wenxin (Vincent) Xu, MD, and Meryl Uranga, discuss renal cell carcinoma in this CME activity titled "Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma." For the full presentation, please visit us at www.peervoice.com/EDH870.

Gesundheit & Medizin
1 von 41
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma

Empfohlen

The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
PeerVoice
 
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
PeerVoice
 
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice
 

Empfohlen

The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
PeerVoice
 
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
PeerVoice
 
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice
 
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
PeerVoice
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
PeerVoice
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
PeerVoice
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
PeerVoice
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
PeerVoice
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
PeerVoice
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
PeerVoice
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
PeerVoice
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
PeerVoice
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
PeerVoice
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
PeerVoice
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
PeerVoice
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
PeerVoice
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
PeerVoice
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
PeerVoice
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
PeerVoice
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
PeerVoice
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
PeerVoice
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
PeerVoice
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
PeerVoice
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
marcuskenyatta275
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Samar Tharwat
 

Weitere ähnliche Inhalte

Mehr von PeerVoice

Mehr von PeerVoice (20)

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
 

Kürzlich hochgeladen

Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
MedicoseAcademics
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
Golden Helix
 

Kürzlich hochgeladen (20)

TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx